S

Sampre Nutritions Ltd
BSE:530617

Watchlist Manager
Sampre Nutritions Ltd
BSE:530617
Watchlist
Price: 18.68 INR 0.43% Market Closed
Market Cap: ₹1.6B

Sampre Nutritions Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sampre Nutritions Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
S
Sampre Nutritions Ltd
BSE:530617
Free Cash Flow
-₹10.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tata Consumer Products Ltd
NSE:TATACONSUM
Free Cash Flow
₹15.1B
CAGR 3-Years
17%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Britannia Industries Ltd
NSE:BRITANNIA
Free Cash Flow
₹19.9B
CAGR 3-Years
31%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Patanjali Foods Ltd
NSE:PATANJALI
Free Cash Flow
₹528m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Marico Ltd
NSE:MARICO
Free Cash Flow
₹14.9B
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Nestle India Ltd
NSE:NESTLEIND
Free Cash Flow
₹42.2B
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

Sampre Nutritions Ltd
Glance View

Market Cap
1.6B INR
Industry
Food Products

Sampre Nutritions Ltd. engages in the manufacture of sugar confectionery. The firm operates through manufacturing and sale of sugar boiled candies and toffees segment. The firm's products/services include manufacturing of sugar confectionery products. The firm is primarily engaged in manufacturing of eclairs for domestic and export market. The firm has two manufacturing facilities including of leasehold unit.

SAMPRE Intrinsic Value
7.17 INR
Overvaluation 62%
Intrinsic Value
Price ₹18.68
S

See Also

What is Sampre Nutritions Ltd's Free Cash Flow?
Free Cash Flow
-10.3m INR

Based on the financial report for Dec 31, 2025, Sampre Nutritions Ltd's Free Cash Flow amounts to -10.3m INR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett